{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:44:10Z","timestamp":1760784250787,"version":"3.40.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM106218","R01 AI111464","R01 GM066170"],"award-info":[{"award-number":["R01 GM106218","R01 AI111464","R01 GM066170"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ejmech.2017.04.001","type":"journal-article","created":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T16:39:16Z","timestamp":1491323956000},"page":"62-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Identification of novel 2-(benzo[ d ]isoxazol-3-yl)-2-oxo- N -phenylacetohydrazonoyl cyanide analoguesas potent EPAC antagonists"],"prefix":"10.1016","volume":"134","author":[{"given":"Na","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingmin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang C.","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2811-1090","authenticated-orcid":false,"given":"Jia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.04.001_bib1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/24884","article-title":"Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP","volume":"396","author":"de Rooij","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2017.04.001_bib2","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1126\/science.282.5397.2275","article-title":"A\u00a0family of cAMP-binding proteins that directly activate Rap1","volume":"282","author":"Kawasaki","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2017.04.001_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrd773","article-title":"Protein kinases\u2013the major drug targets of the twenty-first century?","volume":"1","author":"Cohen","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2017.04.001_bib4","doi-asserted-by":"crossref","first-page":"8561","DOI":"10.1073\/pnas.0503363102","article-title":"Gene expression patterns define key transcriptional events in cell-cycle regulation by cAMP and protein kinase A","volume":"102","author":"Zambon","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2017.04.001_bib5","doi-asserted-by":"crossref","first-page":"9017","DOI":"10.1074\/jbc.R800075200","article-title":"Cyclic nucleotide-regulated cation channels","volume":"284","author":"Biel","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2017.04.001_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-3-540-68964-5_7","article-title":"Cyclic nucleotide-gated channels","author":"Biel","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.04.001_bib7","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1021\/jm401425e","article-title":"Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC)","volume":"57","author":"Chen","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.04.001_bib8","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.bmcl.2017.02.065","article-title":"Exchange proteins directly activated by cAMP (EPACs): emerging therapeutic targets","volume":"27","author":"Wang","year":"2017","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.04.001_bib9","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/cbic.200800216","article-title":"8-pCPT-2'-O-Me-cAMP-AM: an improved Epac-selective cAMP analogue","volume":"9","author":"Vliem","year":"2008","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ejmech.2017.04.001_bib10","doi-asserted-by":"crossref","first-page":"e30441","DOI":"10.1371\/journal.pone.0030441","article-title":"A\u00a0fluorescence-based high-throughput assay for the discovery of exchange protein directly activated by cyclic AMP (EPAC) antagonists","volume":"7","author":"Tsalkova","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2017.04.001_bib11","doi-asserted-by":"crossref","first-page":"18613","DOI":"10.1073\/pnas.1210209109","article-title":"Isoform-specific antagonists of exchange proteins directly activated by cAMP","volume":"109","author":"Tsalkova","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2017.04.001_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1124\/mol.112.080689","article-title":"A\u00a0novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion","volume":"83","author":"Almahariq","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.04.001_bib13","doi-asserted-by":"crossref","first-page":"19615","DOI":"10.1073\/pnas.1314400110","article-title":"Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses","volume":"110","author":"Gong","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2017.04.001_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1042\/BJ20140952","article-title":"Exchange protein directly activated by cAMP modulates regulatory T-cell-mediated immunosuppression","volume":"465","author":"Almahariq","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2017.04.001_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1476-5381.2009.00458.x","article-title":"The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function","volume":"159","author":"Grandoch","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.04.001_bib16","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cellsig.2011.03.007","article-title":"Rap-linked cAMP signaling Epac proteins: compartmentation, functioning and disease implications","volume":"23","author":"Breckler","year":"2011","journal-title":"Cell Signal."},{"key":"10.1016\/j.ejmech.2017.04.001_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.pharmtox.010909.105714","article-title":"Epac: defining a new mechanism for cAMP action","volume":"50","author":"Gloerich","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2017.04.001_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/mol.114.095158","article-title":"Pharmacological inhibition and genetic knockdown of EPAC1 reduce pancreatic cancer metastasis in\u00a0vivo","volume":"87","author":"Almahariq","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.04.001_bib19","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1124\/pr.110.003707","article-title":"Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions","volume":"65","author":"Schmidt","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2017.04.001_bib20","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.tetlet.2013.01.024","article-title":"Efficient synthesis of ESI-09, a novel non-cyclic nucleotide EPAC antagonist","volume":"54","author":"Chen","year":"2013","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2017.04.001_bib21","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1021\/jm3014162","article-title":"Identification and characterization of small molecules as potent and specific EPAC2 antagonists","volume":"56","author":"Chen","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.04.001_bib22","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1016\/j.bmcl.2012.04.082","article-title":"5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP","volume":"22","author":"Chen","year":"2012","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.04.001_bib23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/acsmedchemlett.5b00477","article-title":"Functionalized N,N-diphenylamines as potent and selective EPAC2 inhibitors","volume":"7","author":"Wild","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.04.001_bib24","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1021\/acs.jmedchem.5b00635","article-title":"Structure-activity relationship studies of substituted 2-(isoxazol-3-yl)-2-oxo-N'-phenyl-acetohydrazonoyl cyanide analogues: identification of potent exchange proteins directly activated by cAMP (EPAC) antagonists","volume":"58","author":"Ye","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.04.001_bib25","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.1038\/srep09344","article-title":"Biochemical and pharmacological characterizations of ESI-09 based EPAC inhibitors: defining the ESI-09 \u201ctherapeutic window\u201d","volume":"5","author":"Zhu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2017.04.001_bib26","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1021\/jm301825t","article-title":"Design, synthesis, and biological evaluation of a series of benzo[de][1,7]naphthyridin-7(8H)-ones bearing a functionalized longer chain appendage as novel PARP1 inhibitors","volume":"56","author":"Ye","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.04.001_bib27","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nature04468","article-title":"Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state","volume":"439","author":"Rehmann","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2017.04.001_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nature07187","article-title":"Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B","volume":"455","author":"Rehmann","year":"2008","journal-title":"Nature"},{"year":"2016","series-title":"Small-molecule Drug Discovery Suite 2016-4","key":"10.1016\/j.ejmech.2017.04.001_bib29"},{"year":"2016","series-title":"Schr\u00f6dinger Release 2016-4: Schr\u00f6dinger Suite 2016-4 Protein Preparation Wizard","key":"10.1016\/j.ejmech.2017.04.001_bib30"},{"year":"2016","series-title":"Schr\u00f6dinger Release 2016-4: Maestro","key":"10.1016\/j.ejmech.2017.04.001_bib31"},{"year":"2016","series-title":"Schr\u00f6dinger Release 2016-4: LigPrep","key":"10.1016\/j.ejmech.2017.04.001_bib32"},{"year":"2016","series-title":"Schr\u00f6dinger Release 2016-4: Glide","key":"10.1016\/j.ejmech.2017.04.001_bib33"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417302568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417302568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T19:56:33Z","timestamp":1535918193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417302568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":33,"alternative-id":["S0223523417302568"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.04.001","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of novel 2-(benzo[d]isoxazol-3-yl)-2-oxo-N-phenylacetohydrazonoyl cyanide analoguesas potent EPAC antagonists","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}